Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (561-570 of 645) with videos related to

Pageof 65
Sort By:
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Blood|August 4, 2025
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q 50 years after its discoveryMarco Roncador, Elsa Bernard, Robert P Hasserjian, et al.
Nature Immunology|September 26, 2018
Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemiaHiroki Kato, Ari Itoh-Nakadai, Mitsuyo Matsumoto, et al.
Leukemia|October 17, 2012
The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblastsMaryam Nikpour, Christian Scharenberg, Anquan Liu, et al.
Blood|July 13, 2021
Relationship between clone metrics and clinical outcome in clonal cytopeniaAnna Gallì, Gabriele Todisco, Eulalia Catamo, et al.
Blood|March 30, 2017
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosisPaola Guglielmelli, Annalisa Pacilli, Giada Rotunno, et al.
Blood|April 12, 2013
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasmsElisa Rumi, Daniela Pietra, Paola Guglielmelli, et al.
Haematologica|October 8, 2008
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblastsGhulam J Mufti, John M Bennett, Jean Goasguen, et al.
Nature Cell Biology|March 16, 2022
Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndromeNicola Guzzi, Sowndarya Muthukumar, Maciej Cieśla, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trialsLui G Franciosi, Zuzana Diamant, Katharine H Banner, et al.
Pageof 65

Showing results (561-570 of 645) with videos related to

Sort By:
Pageof 65
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Blood|August 4, 2025
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q 50 years after its discoveryMarco Roncador, Elsa Bernard, Robert P Hasserjian, et al.
Nature Immunology|September 26, 2018
Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemiaHiroki Kato, Ari Itoh-Nakadai, Mitsuyo Matsumoto, et al.
Leukemia|October 17, 2012
The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblastsMaryam Nikpour, Christian Scharenberg, Anquan Liu, et al.
Blood|July 13, 2021
Relationship between clone metrics and clinical outcome in clonal cytopeniaAnna Gallì, Gabriele Todisco, Eulalia Catamo, et al.
Blood|March 30, 2017
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosisPaola Guglielmelli, Annalisa Pacilli, Giada Rotunno, et al.
Blood|April 12, 2013
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasmsElisa Rumi, Daniela Pietra, Paola Guglielmelli, et al.
Haematologica|October 8, 2008
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblastsGhulam J Mufti, John M Bennett, Jean Goasguen, et al.
Nature Cell Biology|March 16, 2022
Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndromeNicola Guzzi, Sowndarya Muthukumar, Maciej Cieśla, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trialsLui G Franciosi, Zuzana Diamant, Katharine H Banner, et al.
Pageof 65